Results 191 to 200 of about 2,148,911 (299)
Conceptual pitfalls in the forest carbon debate : Comment solicited by Prof Yiping (Rocky) Wu, 30 Aug. 2025, revised Dec 2025. [PDF]
Körner C.
europepmc +1 more source
Epilepsy‐Associated Variants of a Single SCN1A Codon Exhibit Divergent Functional Properties
ABSTRACT Objective Pathogenic variants in SCN1A, which encodes the voltage‐gated sodium channel NaV1.1, are associated with multiple epilepsy syndromes exhibiting a range of clinical severity. SCN1A variants are reported in different syndromes, including Dravet syndrome, which is associated with loss‐of‐function, whereas neonatal/infantile‐onset ...
Lanie N. Liebovitz +3 more
wiley +1 more source
Pressure-tolerant Evolution in Rhodopsin of Deep-diving Whales. [PDF]
Takeuchi H, Hayakawa T.
europepmc +1 more source
Multidimensional Profiling of MRI‐Negative Temporal Lobe Epilepsy Uncovers Distinct Phenotypes
ABSTRACT Objective Although hippocampal sclerosis (TLE‐HS) represents the most frequent cause of temporal lobe epilepsy (TLE), up to 30% of patients show no lesion on visual MRI inspection (TLE‐MRIneg). These cases pose diagnostic and therapeutic challenges and are underrepresented in surgical series.
Alice Ballerini +28 more
wiley +1 more source
Epigenetic reprogramming in hematopoietic stem and progenitor cells (HSPCs) and downstream myeloid cells, mediated by H3.3 downregulation and endogenous retroelement (ERE) overexpression, contributes to the progression of multiple sclerosis (MS). ABSTRACT Background Skewed myelopoiesis in the bone marrow has been identified as a key driver of multiple ...
Li‐Mei Xiao +6 more
wiley +1 more source
Experimental investigation of sustainable concrete production using ceramic waste powder as partial fine aggregate replacement. [PDF]
Tariq KA, Adil WA, Salhi A, Waleed A.
europepmc +1 more source
ABSTRACT Objective Onasemnogene abeparvovec (OA) is an AAV9‐based gene therapy for spinal muscular atrophy type I (SMA I). Real‐world outcomes show increased response variability compared to clinical trials, and follow‐up data beyond 12–18 months are limited.
Marika Pane +43 more
wiley +1 more source
Drug Excipients. Necessary but Not Harmless.
Baixauli-Fernández VJ.
europepmc +1 more source
Electrochemical Activation of α-Carbonyl Alkoxyamines for Direct Nucleophilic Substitution. [PDF]
Putziger J, Kandahari E, Lin S.
europepmc +1 more source

